PERUSUGREL - 10

PERUSUGREL - 10 contains Prasugrel, a potent antiplatelet medication that plays a crucial role in preventing blood clots in individuals with certain cardiovascular conditions. This medication is renowned for its effectiveness in reducing the risk of heart attacks and strokes by inhibiting platelet aggregation.

Key Features:

• Active Ingredient: Each tablet of PERUSUGREL - 10 contains 10mg of Prasugrel, ensuring therapeutic efficacy in managing cardiovascular health.
• Mechanism of Action: Prasugrel selectively inhibits the P2Y12 component of ADP receptors on platelets, preventing them from sticking together and forming clots.
• Indications: It is primarily prescribed for patients with acute coronary syndrome who undergo percutaneous coronary intervention (PCI) to reduce the risk of thrombotic cardiovascular events.
• Benefits: Enhances platelet inhibition compared to other antiplatelet agents, reducing the likelihood of ischemic events.

Usage and Dosage:

• Dosage: Typically, a single daily dose of PERUSUGREL - 10 (Prasugrel 10mg) is recommended by healthcare providers following PCI.
• Administration: Administer orally with or without food, as directed by a healthcare professional.

Safety and Precautions:

• Monitoring: Regular monitoring of platelet function tests may be required to ensure appropriate antiplatelet effects.
• Adverse Effects: Common side effects include bleeding tendencies, which may necessitate caution in patients with a history of bleeding disorders.
• Contraindications: Not recommended for patients with a history of stroke, transient ischemic attacks, or active pathological bleeding.

Conclusion:

PERUSUGREL - 10 (Prasugrel 10mg) stands out as a reliable choice for managing cardiovascular health, offering robust platelet inhibition to reduce the risk of thrombotic events post-PCI. It exemplifies modern pharmacotherapy in its ability to enhance patient outcomes through effective antiplatelet therapy.

If You Need More Information About PERUSUGREL - 10 Click here